Do circulating exosomes interfere with vedolizumab efficacy in IBD patients?

被引：0
|
作者：
Domenis, R. [1 ]
Cifu, A. [1 ]
Fabris, M. [1 ,2 ]
Scardino, G. [3 ]
Zilli, M. [3 ]
Marino, M. [3 ]
Curcio, F. [1 ,2 ]
机构：
[1] Univ Hosp Udine, Dipartimento Area Med, Udine, Italy
[2] Univ Hosp Udine, Ist Patol Clin, Udine, Italy
[3] Univ Hosp Udine, Gastroenterol, Udine, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.182
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P058
引用
收藏
页码：S115 / S116
页数：2
相关论文
共 50 条
  • [1] Potential Role of Exosomes in Countering Vedolizumab-Based Therapy in IBD Patients
    Domenis, Rossana
    Cifu, Adriana
    Fabris, Martina
    Scardino, Giulia
    Zilli, Maurizio
    Marino, Marco
    Curcio, Francesco
    FASEB JOURNAL, 2019, 33
  • [2] MAINTENANCE LEVELS OF VEDOLIZUMAB DO NOT CORRELATE WITH CLINICAL REMISSION IN IBD PATIENTS
    Tessolini, Jenna M.
    Bajaj, Girish
    Zezos, Petros
    O'Connell, Jim W.
    Huang, Vivian
    Croitoru, Kenneth
    Steinhart, A. Hillary
    Kelly, Orlaith
    O'Toole, Aoibhlinn
    Kevans, David
    Silverberg, Mark S.
    GASTROENTEROLOGY, 2019, 156 (06) : S1140 - S1140
  • [3] Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort
    Shelton, Edward
    Allegretti, Jessica R.
    Stevens, Betsy
    Lucci, Matthew
    Khalili, Hamed
    Nguyen, Deanna D.
    Sauk, Jenny
    Giallourakis, Cosmas
    Garber, John
    Hamilton, Matthew J.
    Tomczak, Michal
    Makrauer, Fredrick
    Burakoff, Robert B.
    Levine, Jonathan
    de Silva, Punyaganie
    Friedman, Sonia
    Ananthakrishnan, Ashwin
    Korzenik, Joshua R.
    Yajnik, Vijay
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (12) : 2879 - 2885
  • [4] Efficacy of vedolizumab as induction therapy in refractory IBD patients: a multicentre cohort
    Shelton, E.
    Allegretti, J.
    Stevens, B.
    Lucci, M.
    Ananthakrishnan, A.
    Yajnik, V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 138 - 139
  • [5] Efficacy of Vedolizumab in Older IBD Patients Based on Prior Biologic Exposure
    Patel, Devin B.
    Cohen, Erica
    Ha, Christina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S455 - S455
  • [6] The Possible Role of Circulating Exosomes in the Sequestration of Vedolizumab in Patients Affected by Inflammatory Bowel Disease
    Cifu, A.
    Domenis, R.
    Marino, M.
    Scardino, G.
    Zilli, M.
    Fabris, M.
    Curcio, F.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : S100 - S101
  • [7] VEDOLIZUMAB - PERIOPERATIVE INFECTION RATES IN PATIENTS WITH IBD
    Mehta, Ripple
    Abidian, Mohamed Modar
    Bayasi, Mohammed
    Mattar, Mark
    GASTROENTEROLOGY, 2020, 158 (06) : S962 - S963
  • [8] Effectiveness of Vedolizumab Induction Therapy in IBD Patients
    Kaymak, Tanay
    Niess, Jan H.
    Hruz, Petr
    SWISS MEDICAL WEEKLY, 2017, 147 : 16S - 16S
  • [9] Vedolizumab Efficacy and Safety in a Tertiary Care IBD Clinical Practice
    Vivio, Emily
    Kanuri, Navya D.
    Dey, Neelendu
    Chen, Chien-Huan
    Gutierrez, Alexandra
    Ciorba, Matthew A.
    GASTROENTEROLOGY, 2015, 148 (04) : S871 - S872
  • [10] The Efficacy and Safety of Calcineurin Inhibitors in Inducing and Maintaining Clinical Remission in IBD Patients Commencing Vedolizumab
    Christensen, Britt
    Goeppinger, Sarah R.
    Colman, Ruben J.
    Siddiqui, Dania
    Yarur, Andres
    Hirsch, Ayal
    Bochenek, Ashley A.
    Wichmann, Alana
    Sakuraba, Atsushi
    Cohen, Russell D.
    Rubin, David T.
    GASTROENTEROLOGY, 2015, 148 (04) : S866 - S866
12345